Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.75 - $1.49 $86,835 - $172,512
-115,780 Reduced 31.23%
254,987 $318,000
Q3 2023

Nov 14, 2023

BUY
$1.23 - $2.25 $1,093 - $2,000
889 Added 0.24%
370,767 $481,000
Q2 2023

Aug 14, 2023

BUY
$1.24 - $1.92 $66,224 - $102,541
53,407 Added 16.88%
369,878 $636,000
Q1 2023

May 15, 2023

SELL
$1.34 - $2.62 $46,957 - $91,812
-35,043 Reduced 9.97%
316,471 $462,000
Q4 2022

Feb 14, 2023

BUY
$1.44 - $3.44 $62,160 - $148,494
43,167 Added 14.0%
351,514 $569,000
Q3 2022

Nov 14, 2022

BUY
$3.35 - $5.55 $68,524 - $113,525
20,455 Added 7.11%
308,347 $1.03 Million
Q2 2022

Aug 15, 2022

BUY
$3.12 - $7.52 $898,223 - $2.16 Million
287,892 New
287,892 $1.05 Million
Q1 2021

May 17, 2021

SELL
$27.0 - $32.48 $324,729 - $390,636
-12,027 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$26.68 - $38.23 $320,880 - $459,792
12,027 New
12,027 $359,000

Others Institutions Holding KRON

About Kronos Bio, Inc.


  • Ticker KRON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,769,100
  • Market Cap $51.1M
  • Description
  • Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...
More about KRON
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.